CBD Unlimited has initiated a collaboration with veterinarians, horse caretakers, trainers and other equine experts to study the potential health benefits and applications of CBD for horses. This trial will be led by certified vets and researchers to ensure that through the testing process, the Company will determine the optimum dosage, potency and safety of the product throughout the trial’s duration.

According to a study published by Market Study Report LLC., the equine supplement industry is projected to grow from 1 billion in 2018 to 1.25 billion by 2025.

“This initial testing phase for our equine CBD product marks a key milestone for the Company,” commented Mr. Todd Davis, CEO and Chairman of CBD Unlimited. “We are excited to expand our animal product pipeline by providing safe and natural therapies for larger animals. We are thankful for the endless support from our development team and equine professionals who are taking the lead on this study. Our product is formulated to optimize the delivery of CBD in to targeted areas of the body at a specific dosing range. The product is also designed to reduce irritation to the GI Tract of the horse while recovering from other conditions that cause discomfort for horses.”

According to the Brightfield Group, the CBD pet market is projected to hit $1.7 Billion by 2023, and the Company strives to be at the forefront of the hemp-derived product market. CBD Unlimited has been devoted to formulating multi-spectrum hemp CBD products not only for people but for dogs and cats with its Phyto-Bites line. Following a successful roll-out of CBD pet products and showcasing at SuperZoo Expo 2019, the Company has seen an increased demand in hemp products for pets.

The Company is prepared to pursue a new line of hemp products to serve the unmet need for natural and plant-based therapeutic solutions for larger animals such as horses. The “TrailRMix” line for horses will deliver the same purpose for healthful benefits that Phyto-Bytes have become known for but in formulations and concentrations specific to meet the needs of equine breeds. CBD Unlimited manufactured 800 kilos of its pellet formulation in order for equine professionals to have a substantial amount of product to test during this first trial phase.

About CBD Unlimited, Inc.

CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.

In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity while reducing costs for retailers and costs in time for customers.